OsI_23686 Antibody

Basic Research Questions

• What is OsI_23686 Antibody and what are its biochemical properties?

OsI_23686 Antibody is a rabbit polyclonal antibody that targets OsI_020954 (Profilin LP04), a protein from Oryza sativa subsp. indica (Rice) with a molecular weight of 14,133 Da. It's an IgG isotype antibody produced through antigen-affinity purification methods using recombinant Oryza sativa subsp. indica OsI_020954 protein as the immunogen .

The antibody is formulated as a liquid with 0.03% Proclin 300 as a preservative, in 50% Glycerol, 0.01M PBS, pH 7.4. Its target protein (Profilin LP04) has known actin-binding properties and affects cytoskeleton structure, while also interacting with PIP2 to inhibit the formation of IP3 and DG .

• How should I validate OsI_23686 Antibody for my specific application?

Antibody validation requires a systematic approach to ensure reliability and reproducibility:

• Literature validation: Review published studies using the antibody in applications similar to yours. Be cautious of discrepancies in reported molecular weights or expression patterns, which may indicate non-specific binding .

• Experimental validation: Implement the following validation strategy:

• Signal verification: For Western blot, confirm the detected protein matches the expected molecular weight (14.1 kDa for OsI_020954) .

• What applications is OsI_23686 Antibody suitable for and what are the recommended protocols?

OsI_23686 Antibody has been validated for ELISA and Western Blot applications . Here are protocol recommendations:

Western Blot Protocol:

• Separate proteins via SDS-PAGE

• Transfer to membrane (PVDF or nitrocellulose)

• Block with 5% BSA or non-fat milk in TBST for 1 hour at room temperature

• Dilute OsI_23686 Antibody (determine optimal dilution through titration, typically 1:500 to 1:2000)

• Incubate with primary antibody overnight at 4°C

• Wash 3-5 times with TBST

• Incubate with HRP-conjugated secondary anti-rabbit antibody

• Develop using ECL substrate

ELISA Protocol:

• Coat plate with antigen or capture antibody

• Block with appropriate buffer

• Apply primary antibody (OsI_23686) at optimized dilution

• Apply enzyme-conjugated secondary antibody

• Add substrate and measure signal

Optimization through titration experiments is critical for both applications to determine the ideal antibody concentration that maximizes specific signal while minimizing background .

• How should I store and handle OsI_23686 Antibody to maintain its activity?

Proper storage and handling are crucial for maintaining antibody performance:

• Store at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles (aliquot upon first thaw)

• Briefly centrifuge vials before opening to collect liquid that may be trapped in the cap

• Keep on ice when working with the antibody

• For long-term storage, add carrier protein (BSA, 0.1-1%) if not already present

• Record lot numbers and maintain documentation of performance for each lot

A study on monoclonal antibody formulations showed that stability can be significantly affected by buffer conditions, with optimal thermostability achieved through careful pH and excipient selection .

Advanced Research Questions

• How does the polyclonal nature of OsI_23686 Antibody influence experimental design and data interpretation?

OsI_23686 is a polyclonal antibody, which has significant implications for experimental design:

Characteristics of polyclonal antibodies and their experimental impact:

• What advanced controls should be implemented when using OsI_23686 Antibody in multi-parameter experiments?

For complex experimental designs, comprehensive controls are essential:

Technical controls:

• Single-stain controls for each fluorophore (if using fluorescent detection)

• Fluorescence Minus One (FMO) controls to define gating boundaries in flow cytometry

• Isotype controls at the same concentration as the primary antibody

• Absorption controls using recombinant target protein

Biological controls:

• Species-matched irrelevant antibody controls

• Genetic knockout or knockdown models

• Competition with purified antigen

• Parallel staining with a validated antibody targeting a different epitope on the same protein

In flow cytometry experiments with OsI_23686 Antibody, implementing a blocking strategy is critical—use both FcR blocking and True-stain monocyte Blocker if working with myeloid cells, as demonstrated in studies showing significant reduction in background signal with proper blocking techniques .

• How can I quantitatively assess OsI_23686 Antibody binding characteristics to optimize experimental conditions?

Quantitative assessment of antibody binding properties enables rational optimization:

Binding affinity determination:

• Surface Plasmon Resonance (SPR) to measure on/off rates and KD

• Bio-Layer Interferometry for real-time binding kinetics

• Enzyme-Linked Immunosorbent Assay (ELISA) for relative affinity measurements

Antibody titration experiments:

• Prepare a serial dilution series of antibody

• Test each dilution under identical conditions

• Plot signal-to-noise ratio vs. antibody concentration

• Select concentration at maximum S/N ratio

Studies on antibody characterization demonstrate that optimal concentration is reached when the condition produces the largest distance between positive and negative populations, maximizing bandwidth/resolution .

• What strategies can I employ to address cross-reactivity issues with OsI_23686 Antibody?

Cross-reactivity is a common challenge with antibodies that requires systematic troubleshooting:

Identification of cross-reactivity:

• Test against panels of related proteins

• Perform epitope mapping to identify specific binding regions

• Use mass spectrometry to identify all proteins precipitated by the antibody

Mitigation strategies:

• Adjust antibody concentration (lower concentrations may reduce non-specific binding)

• Optimize blocking conditions using different agents (BSA, milk, commercial blockers)

• Increase wash stringency with higher salt concentrations or mild detergents

• Use higher dilutions of antibody with longer incubation times

• Pre-absorb antibody with related proteins to deplete cross-reactive antibodies

Research on antibody specificity has shown that even highly specific antibodies can demonstrate unexpected cross-reactivity under certain conditions, making validation in the specific experimental context essential .

• How can I use OsI_23686 Antibody in multiplex assays while minimizing interference?

Multiplexing with OsI_23686 Antibody requires careful consideration of potential interactions:

Antibody compatibility assessment:

• Test for antibody cross-reactivity through sequential immunoprecipitation

• Evaluate epitope accessibility in fixed/native conformations

• Verify compatibility of detection systems (fluorophores, enzyme conjugates)

Multiplex optimization strategies:

• For fluorescent applications, select fluorophores with minimal spectral overlap

• Implement spillover/compensation controls for accurate signal separation

• For multiplexed immunohistochemistry, use sequential staining with proper blocking between rounds

Research on panel design for flow cytometry demonstrates that when co-expressed markers are labeled with spectrally similar fluorophores, significant data spread can occur, compromising the resolution of positive and negative populations .

• How does OsI_23686 Antibody performance compare across different sample types and preparation methods?

Sample preparation significantly impacts antibody performance:

Comparative performance across sample preparations:

Studies on fixation effects demonstrate that paraformaldehyde can significantly alter epitope accessibility, with variable effects depending on the specific antibody-antigen pair. Researchers should validate OsI_23686 with each preparation method rather than assuming transferability across methods .

• What role can OsI_23686 Antibody play in understanding protein-protein interactions?

OsI_23686 Antibody can be leveraged for protein interaction studies through several approaches:

Co-immunoprecipitation optimization:

• Determine if antibody binding interferes with protein interaction domains

• Select lysis conditions that preserve native protein complexes

• Verify antibody efficiency in immunoprecipitation before interaction studies

• Consider cross-linking approaches for transient interactions

Proximity ligation assays:

• Combine OsI_23686 with antibodies against suspected interaction partners

• Validate specificity of each antibody independently

• Include proper controls (non-interacting proteins as negative controls)

Studies on public antibody responses to antigens demonstrate that understanding the epitope targeted by the antibody is crucial for interpreting interaction data, as binding to specific domains may disrupt or stabilize certain protein-protein interactions .

• How can I integrate computational approaches to enhance experimental design and data interpretation with OsI_23686 Antibody?

Computational tools can significantly enhance antibody-based experiments:

Epitope prediction and analysis:

• Use sequence alignment to identify conserved regions across related proteins

• Employ epitope prediction algorithms to identify likely binding regions

• Model structural impacts of mutations on antibody binding sites

Machine learning for specificity prediction:

• Deep learning models have been successfully applied to distinguish antibodies with different antigen specificities

• A study on SARS-CoV-2 antibodies demonstrated that a deep learning model could accurately differentiate between antibodies targeting SARS-CoV-2 spike protein and those targeting influenza hemagglutinin based on sequence features

Experimental design optimization:

• Power calculations to determine appropriate sample sizes

A DOE approach for antibody formulation screening identified optimal buffer compositions that maximized stability and minimized non-specific binding, demonstrating the value of systematic multivariable testing over one-factor-at-a-time optimization .